Ken Griffin Dario Health Corp. Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$1.09 - $1.9 $2,071 - $3,610	1,900 Added 135.71%	3,300 $3,000
Q1 2024 May 15, 2024	SELL	$1.4 - $2.55 $979 - $1,784	-700 Reduced 33.33%	1,400 $2,000
Q4 2023 Feb 14, 2024	SELL	$1.0 - $3.39 $1,800 - $6,102	-1,800 Reduced 46.15%	2,100 $3,000
Q3 2023 Nov 14, 2023	SELL	$2.6 - $4.23 $11,960 - $19,458	-4,600 Reduced 54.12%	3,900 $12,000
Q2 2023 Aug 14, 2023	SELL	$3.2 - $4.33 $58,560 - $79,239	-18,300 Reduced 68.28%	8,500 $34,000
Q1 2023 May 15, 2023	SELL	$3.79 - $6.22 $18,571 - $30,478	-4,900 Reduced 15.46%	26,800 $110,000
Q4 2022 Feb 14, 2023	BUY	$3.53 - $5.49 $12,002 - $18,666	3,400 Added 12.01%	31,700 $135,000
Q3 2022 Nov 14, 2022	BUY	$3.74 - $7.09 $56,474 - $107,059	15,100 Added 114.39%	28,300 $131,000

8.01M

55.5K

3.3K

Ticker DRIO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 23,295,000
Market Cap $21.4M
Description
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.